After today’s positive trading update, Executive Chairman Jay Lecoque of SourceBio International takes Paul Hill through the details:
Timestamps
00:00 Tremendous underlying demand being experienced in the Cellular Pathology operation (SBI)
03:24 Integration & synergies from the LDPath acquisition (SBI)
05:16 Planned capacity expansion (SBI)
06:06 Introduction of AI (SBI)
08:09 Genomics division &; opportunity in Precision Medicine. (SBI)
10:19 Stability Storage (SBI)
11:22 Repurposing Covid testing resource & equipment (SBI)
12:30 Possible future M&A (SBI)
13:02 SBI’s overall outlook for (SBI)
